The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

Epicardial fat thickness is associated with cardiovascular disease. Mineralocorticoid receptor antagonist (MRA), a pharmaceutical treatment for CVD, was found to have an effect on adipose tissue. Our aim was to analyse the main epicardial fat genesis and inflammation-involved cell markers and their...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Xiaoran, Almenglo, Cristina, Fernandez, Ángel Luis, Martínez-Cereijo, José Manuel, Iglesias-Alvarez, Diego, Duran-Muñoz, Darío, García-Caballero, Tomás, Gonzalez-Juanatey, Jose Ramón, Rodriguez-Mañero, Moises, Eiras, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027091/
https://www.ncbi.nlm.nih.gov/pubmed/35455943
http://dx.doi.org/10.3390/cells11081264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027091/
https://www.ncbi.nlm.nih.gov/pubmed/35455943
http://dx.doi.org/10.3390/cells11081264

Ejemplares similares